CRSR Q3 Beat Lifts Guidance, But Memory Margin Normalization Keeps Risk

What happened

Corsair reported Q3 results that beat guidance, led by strong memory demand and a 6% YoY revenue increase, and raised its full-year 2026 outlook to $1.456–$1.486B revenue and $127–$131M adjusted EBITDA. Management pointed to holiday demand, delayed peripheral launches, and the Trak Racer acquisition as drivers for expected double-digit Q4 peripherals growth, alongside $6–$7M of backlog conversion. However, the company cautioned that memory gross margin is normalizing to 18–20% in Q4, down from 35% a year ago, which will pressure profitability even as revenue stays supported. The Q3 filing also revealed that non-memory component revenue fell 33.8% YoY, reflecting ongoing weakness in DIY PC demand, and inventory levels rose sharply, signaling a working-capital build. The stock closed at $11.84 after the call, still up 46% over the past year but facing valuation at 26x EV/EBITDA with no margin of safety per our analysis.

Implication

The current setup requires proof that delayed peripheral launches and holiday demand convert into double-digit Q4 growth and improved gross margin, not just revenue recognition. If Q4 memory gross margin falls below 18%, peripherals miss double-digit growth, or inventory stays elevated after the holiday, we would reduce our base-case value toward $9.00 and treat the stock as a sell on rallies. Conversely, if Q4 peripherals grow above 12%, memory margin lands within guidance, and non-memory components stabilize by the next filing, our conviction would increase, supporting a re-rating toward $15.00. Until that evidence arrives, we maintain a WAIT rating with a trim above $14.50 and an attractive entry near $9.50, monitoring quarterly filings for signals rather than chasing the stock. We also need management to quantify software or ecosystem monetization to justify a higher multiple; otherwise, the current EV/EBITDA of 26 leaves little room for error.

Thesis delta

This news does not change our thesis; it confirms the near-term execution story but does not resolve the key uncertainty around margin normalization and DIY weakness. Our WAIT rating and scenario probabilities remain unchanged, with the base case valuing the stock at $12.50 versus the current $11.84.